Global Imaging Market to Reach $26.6 B
The global diagnostic imaging market is expected to swell to $26.6 billion by 2016, driven by an aging population and advancements in the field.
The global diagnostic imaging market is expected to swell to $26.6 billion by 2016, driven by an aging population and advancements in the field.
The imaging market, which stood at $20.7 billion in 2010, is also expected to be bolstered by an increasing awareness about preventive care and development of products “that result in harmless imaging,” according to research firm MarketsandMarkets, whose report analyzes and studies major market drivers.
The market is expected to grow at a compound annual growth rate of 4.2 percent, according to the report which examined geography, forecasting revenues, and trends in X-ray, CT, MRI, ultrasound and nuclear imaging.
Topping the imaging trends garnering attention is the fusion of nuclear imaging with different modalities, such as PET/CT, SPECT/CT, and MRI/PET, according to the report. Portable diagnostic equipment is also facing demand, according to analysts.
In 2010, X-ray constituted the largest percent of market share with around 34 percent, followed by ultrasound at 21 percent, CT scan with 19.5 percent, MRI with 18.5 percent, and nuclear medicine with 7 percent. America dominates the market with around 36.6 percent market share, followed by Europe with 27.3 percent, and Asia with 27 percent. GE, Philips, and Siemens constituted the majority of the market. Toshiba, Hitachi, and Hologic are gaining presences, according to analysts.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
